These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 9863556)

  • 1. Modeling dopamine system dysfunction in experimental animals.
    Hantraye P
    Nucl Med Biol; 1998 Nov; 25(8):721-8. PubMed ID: 9863556
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dopamine receptor classification, neuroanatomical distribution and in vivo imaging.
    Brücke T; Wenger S; Podreka I; Asenbaum S
    Wien Klin Wochenschr; 1991; 103(21):639-46. PubMed ID: 1771898
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Investigating the dopaminergic synapse in vivo. I. Molecular imaging studies in humans.
    Nikolaus S; Antke C; Kley K; Poeppel TD; Hautzel H; Schmidt D; Müller HW
    Rev Neurosci; 2007; 18(6):439-72. PubMed ID: 18330212
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Dopaminergic modulation of cerebral activity and cognitive functions].
    Jucaite A
    Medicina (Kaunas); 2002; 38(4):357-62. PubMed ID: 12474782
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PET measurements of dopaminergic pathways in the brain.
    Perlmutter JS; Moerlein SM
    Q J Nucl Med; 1999 Jun; 43(2):140-54. PubMed ID: 10429509
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PET study of the pre- and post-synaptic dopaminergic markers for the neurodegenerative process in Huntington's disease.
    Ginovart N; Lundin A; Farde L; Halldin C; Bäckman L; Swahn CG; Pauli S; Sedvall G
    Brain; 1997 Mar; 120 ( Pt 3)():503-14. PubMed ID: 9126061
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo imaging of synaptic function in the central nervous system: I. Movement disorders and dementia.
    Nikolaus S; Antke C; Müller HW
    Behav Brain Res; 2009 Dec; 204(1):1-31. PubMed ID: 19523490
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Normal database of dopaminergic neurotransmission system in human brain measured by positron emission tomography.
    Ito H; Takahashi H; Arakawa R; Takano H; Suhara T
    Neuroimage; 2008 Jan; 39(2):555-65. PubMed ID: 17962043
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dopaminergic treatment weakens medium spiny neuron collateral inhibition in the parkinsonian striatum.
    Wei W; Ding S; Zhou FM
    J Neurophysiol; 2017 Mar; 117(3):987-999. PubMed ID: 27927785
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radiotracer imaging of dopaminergic transmission in neuropsychiatric disorders.
    Verhoeff NP
    Psychopharmacology (Berl); 1999 Dec; 147(3):217-49. PubMed ID: 10639681
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dopaminergic and cholinergic lesions in progressive supranuclear palsy.
    Ruberg M; Javoy-Agid F; Hirsch E; Scatton B; LHeureux R; Hauw JJ; Duyckaerts C; Gray F; Morel-Maroger A; Rascol A
    Ann Neurol; 1985 Nov; 18(5):523-9. PubMed ID: 3000280
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neurodegenerative movement disorders: the contribution of functional imaging.
    Piccini P
    Curr Opin Neurol; 2004 Aug; 17(4):459-66. PubMed ID: 15247543
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Compensations after lesions of central dopaminergic neurons: some clinical and basic implications.
    Zigmond MJ; Abercrombie ED; Berger TW; Grace AA; Stricker EM
    Trends Neurosci; 1990 Jul; 13(7):290-6. PubMed ID: 1695406
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of dopamine for the pathophysiology of schizophrenia.
    Meisenzahl EM; Schmitt GJ; Scheuerecker J; Möller HJ
    Int Rev Psychiatry; 2007 Aug; 19(4):337-45. PubMed ID: 17671867
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular imaging of the dopaminergic system and its association with human cognitive function.
    Cropley VL; Fujita M; Innis RB; Nathan PJ
    Biol Psychiatry; 2006 May; 59(10):898-907. PubMed ID: 16682268
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Progressive striatal and cortical dopamine receptor dysfunction in Huntington's disease: a PET study.
    Pavese N; Andrews TC; Brooks DJ; Ho AK; Rosser AE; Barker RA; Robbins TW; Sahakian BJ; Dunnett SB; Piccini P
    Brain; 2003 May; 126(Pt 5):1127-35. PubMed ID: 12690052
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dopaminergic modulation of excitatory postsynaptic currents in rat neostriatal neurons.
    Umemiya M; Raymond LA
    J Neurophysiol; 1997 Sep; 78(3):1248-55. PubMed ID: 9310416
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The relationship between locomotor disability, autonomic dysfunction, and the integrity of the striatal dopaminergic system in patients with multiple system atrophy, pure autonomic failure, and Parkinson's disease, studied with PET.
    Brooks DJ; Salmon EP; Mathias CJ; Quinn N; Leenders KL; Bannister R; Marsden CD; Frackowiak RS
    Brain; 1990 Oct; 113 ( Pt 5)():1539-52. PubMed ID: 2123119
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of dopamine in cognition: evidence from functional imaging studies.
    Remy P; Samson Y
    Curr Opin Neurol; 2003 Dec; 16 Suppl 2():S37-41. PubMed ID: 15129849
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Functional role and pharmacological regulation of the dopaminergic system of the brain].
    Raevskiĭ KS
    Vestn Ross Akad Med Nauk; 1998; (8):19-24. PubMed ID: 9771125
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.